[Federal Register Volume 61, Number 150 (Friday, August 2, 1996)]
[Notices]
[Page 40451]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-19688]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE
Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on June 6, 1996, Ansys, Inc., 2 
Goodyear, Irvine, California 92718, made application to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of benzoylecgonine (9180) a basic class of controlled 
substance listed in Schedule II.
    The firm plans to manufacture benzoylecgonine to produce standards 
and controls for in-vitro diagnostic drug testing systems.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than October 1, 1996.

    Dated: July 25, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-19688 Filed 8-1-96; 8:45 am]
BILLING CODE 4410-09-M